CD14 Facilitates Invasive Respiratory Tract Infection by Streptococcus pneumoniae
Mark C. Dessing1,2,
Sylvia Knapp1,2,
Sandrine Florquin3,
Alex F. de Vos1,2 and
Tom van der Poll1,2
1 Center for Infection and Immunity Amsterdam, 2 Center for Experimental and Molecular Medicine, and 3 Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Correspondence and requests for reprints should be addressed to Mark C. Dessing, Center for Experimental and Molecular Medicine, Room G2130, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. E-mail: m.c.dessing{at}amc.uva.nl
Rationale: CD14 is a pattern recognition receptor that can interactwith a variety of bacterial ligands. During gram-negative infection,CD14 plays an important role in the induction of a protectiveimmune response by virtue of its capacity to recognize lipopolysaccharidein the bacterial cell wall. Knowledge of the contribution ofCD14 to host defense against gram-positive infections is limited.
Objectives: To study the role of CD14 in gram-positive bacterialpneumonia.
Methods: CD14 knockout (KO) and normal wild-type (WT) mice wereintranasally infected with Streptococcus pneumoniae.
Measurements and Main Results: CD14 KO mice demonstrated a stronglyreduced lethality, which was accompanied by a more than 10-foldlower bacterial load in lung homogenates but not in bronchoalveolarlavage fluid at 48 hours after infection. Strikingly, CD14 KOmice failed to develop positive blood cultures, whereas WT micehad positive blood cultures from 24 hours onward and eventuallyinvariably had evidence of systemic infection. Lung inflammationwas attenuated in CD14 KO mice at 48 hours after infection,as evaluated by histopathology and cytokine and chemokine levels.Intrapulmonary delivery of recombinant soluble CD14 to CD14KO mice rendered them equally susceptible to S. pneumoniae asWT mice, resulting in enhanced bacterial growth in lung homogenatesand bacteremia, indicating that the presence of soluble CD14in the bronchoalveolar compartment is sufficient to cause invasivepneumococcal disease.
Conclusion: These data suggest that S. pneumoniae uses (soluble)CD14 present in the bronchoalveolar space to cause invasiverespiratory tract infection.
Scientific Knowledge on the Subject
CD14 has a central rolein host defense against gram-negative infection. The contributionof CD14 in gram-positive infection is limited.
What This StudyAdds to the Field
CD14, either cell bound or soluble, facilitatesinvasive pneumococcal disease during respiratory tract infectionwith Streptococcus pneumoniae.
This article has been cited by other articles:
G. Schabbauer, U. Matt, P. Gunzl, J. Warszawska, T. Furtner, E. Hainzl, I. Elbau, I. Mesteri, B. Doninger, B. R. Binder, et al. Myeloid PTEN Promotes Inflammation but Impairs Bactericidal Activities during Murine Pneumococcal Pneumonia
J. Immunol.,
July 1, 2010;
185(1):
468 - 476.
[Abstract][Full Text][PDF]
L. J. Quinton, M. R. Jones, B. E. Robson, and J. P. Mizgerd Mechanisms of the Hepatic Acute-Phase Response during Bacterial Pneumonia
Infect. Immun.,
June 1, 2009;
77(6):
2417 - 2426.
[Abstract][Full Text][PDF]
M. A. D. van Zoelen, M. Schouten, A. F. de Vos, S. Florquin, J. C. M. Meijers, P. P. Nawroth, A. Bierhaus, and T. van der Poll The Receptor for Advanced Glycation End Products Impairs Host Defense in Pneumococcal Pneumonia
J. Immunol.,
April 1, 2009;
182(7):
4349 - 4356.
[Abstract][Full Text][PDF]
M. Leendertse, R. J.L. Willems, I. A.J. Giebelen, J. J.T.H. Roelofs, N. van Rooijen, M. J.M. Bonten, and T. van der Poll Peritoneal macrophages are important for the early containment of Enterococcus faecium peritonitis in mice
Innate Immunity,
February 1, 2009;
15(1):
3 - 12.
[Abstract][PDF]
I. A. J. Giebelen, M. Leendertse, S. Florquin, and T. van der Poll Stimulation of acetylcholine receptors impairs host defence during pneumococcal pneumonia
Eur. Respir. J.,
February 1, 2009;
33(2):
375 - 381.
[Abstract][Full Text][PDF]
R. A. Fowler, N. K. J. Adhikari, D. C. Scales, W. L. Lee, and G. D. Rubenfeld Update in Critical Care 2007
Am. J. Respir. Crit. Care Med.,
April 15, 2008;
177(8):
808 - 819.
[Full Text][PDF]
M. Leendertse, R. J. L. Willems, I. A. J. Giebelen, P. S. van den Pangaart, W. J. Wiersinga, A. F. de Vos, S. Florquin, M. J. M. Bonten, and T. van der Poll TLR2-Dependent MyD88 Signaling Contributes to Early Host Defense in Murine Enterococcus faecium Peritonitis
J. Immunol.,
April 1, 2008;
180(7):
4865 - 4874.
[Abstract][Full Text][PDF]
J. Goulding, R. Snelgrove, J. Saldana, A. Didierlaurent, M. Cavanagh, E. Gwyer, J. Wales, E. L. Wissinger, and T. Hussell Respiratory Infections: Do We Ever Recover?
Proceedings of the ATS,
December 1, 2007;
4(8):
618 - 625.
[Abstract][Full Text][PDF]